IL158250A0 - 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds - Google Patents
3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compoundsInfo
- Publication number
- IL158250A0 IL158250A0 IL15825002A IL15825002A IL158250A0 IL 158250 A0 IL158250 A0 IL 158250A0 IL 15825002 A IL15825002 A IL 15825002A IL 15825002 A IL15825002 A IL 15825002A IL 158250 A0 IL158250 A0 IL 158250A0
- Authority
- IL
- Israel
- Prior art keywords
- diazabicyclo
- formulations
- antiarrhythmic compounds
- antiarrhythmic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101327A SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | New crystalline forms |
| PCT/SE2002/000725 WO2002083688A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158250A0 true IL158250A0 (en) | 2004-05-12 |
Family
ID=20283783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15825002A IL158250A0 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7217708B2 (et) |
| EP (2) | EP1550663A1 (et) |
| JP (1) | JP2004525970A (et) |
| KR (1) | KR20030087078A (et) |
| CN (1) | CN1269823C (et) |
| AR (1) | AR035452A1 (et) |
| AT (1) | ATE323095T1 (et) |
| BR (1) | BR0208829A (et) |
| CA (1) | CA2443470A1 (et) |
| CZ (1) | CZ20032760A3 (et) |
| DE (1) | DE60210598T2 (et) |
| DK (1) | DK1389213T3 (et) |
| EE (1) | EE200300504A (et) |
| ES (1) | ES2261721T3 (et) |
| HK (1) | HK1061026A1 (et) |
| HU (1) | HUP0303487A3 (et) |
| IL (1) | IL158250A0 (et) |
| IS (1) | IS6980A (et) |
| MX (1) | MXPA03009206A (et) |
| NO (1) | NO20034527L (et) |
| NZ (1) | NZ528560A (et) |
| PL (1) | PL367179A1 (et) |
| PT (1) | PT1389213E (et) |
| RU (1) | RU2286993C2 (et) |
| SE (1) | SE0101327D0 (et) |
| SK (1) | SK12572003A3 (et) |
| TW (1) | TWI237025B (et) |
| UA (1) | UA74629C2 (et) |
| WO (1) | WO2002083688A1 (et) |
| ZA (1) | ZA200307759B (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| SE0401539D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| SE0401540D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| AU2006258293B2 (en) * | 2005-06-13 | 2010-06-17 | Astrazeneca Ab | New oxabispidine compounds for the treatment of cardiac arrhythmias |
| AR053901A1 (es) * | 2005-06-20 | 2007-05-23 | Astrazeneca Ab | Formas fisicas de oxabispidinas n,n'- disustituidas |
| KR20080028435A (ko) * | 2005-06-20 | 2008-03-31 | 아스트라제네카 아베 | Ｎ,ｎ’-이치환된 옥사비스피딘의 제조 방법 |
| TW200734342A (en) * | 2005-12-15 | 2007-09-16 | Astrazeneca Ab | New compounds for the treatment of cardiac arrhythmias |
| WO2007103970A2 (en) * | 2006-03-07 | 2007-09-13 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| DK3357911T3 (da) | 2006-06-26 | 2022-07-04 | Akebia Therapeutics Inc | Prolylhydroxylaseinhibitorer og fremgangsmåder til anvendelse |
| NO2686520T3 (et) | 2011-06-06 | 2018-03-17 | ||
| US20120329836A1 (en) | 2011-06-06 | 2012-12-27 | The Ohio State University | Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer |
| US11857543B2 (en) | 2013-06-13 | 2024-01-02 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| CR20200220A (es) | 2013-11-15 | 2020-11-18 | Akebia Therapeutics Inc | FORMAS SÓLIDAS DE ÁCIDO {[5-(3-CLOROFENIL)-3-HIDROXIPIRIDIN-2-CARBONIL]AMINO}ACÉTICO, COMPOSICIONES, Y USOS DE LAS MISMAS (Divisional 2016-0222) |
| JP2018502882A (ja) | 2015-01-23 | 2018-02-01 | アケビア セラピューティクス インコーポレイテッドＡｋｅｂｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | ２−（５−（３−フルオロフェニル）−３−ヒドロキシピコリンアミド）酢酸の固体形態、その組成物及び使用 |
| MX2017012460A (es) | 2015-04-01 | 2018-01-30 | Akebia Therapeutics Inc | Composiciones y metodos para el tratamiento de la anemia. |
| TWI822776B (zh) | 2018-05-09 | 2023-11-21 | 美商阿克比治療有限公司 | 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法 |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| SE9704709D0 (sv) | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| SE9902268D0 (sv) | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
-
2001
- 2001-04-12 SE SE0101327A patent/SE0101327D0/xx unknown
-
2002
- 2002-04-01 TW TW091106493A patent/TWI237025B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101189A patent/AR035452A1/es not_active Application Discontinuation
- 2002-04-12 RU RU2003129231/04A patent/RU2286993C2/ru not_active IP Right Cessation
- 2002-04-12 JP JP2002581443A patent/JP2004525970A/ja active Pending
- 2002-04-12 KR KR10-2003-7013320A patent/KR20030087078A/ko not_active Application Discontinuation
- 2002-04-12 PT PT02761972T patent/PT1389213E/pt unknown
- 2002-04-12 CA CA002443470A patent/CA2443470A1/en not_active Abandoned
- 2002-04-12 DK DK02761972T patent/DK1389213T3/da active
- 2002-04-12 IL IL15825002A patent/IL158250A0/xx unknown
- 2002-04-12 PL PL02367179A patent/PL367179A1/xx unknown
- 2002-04-12 MX MXPA03009206A patent/MXPA03009206A/es active IP Right Grant
- 2002-04-12 AT AT02761972T patent/ATE323095T1/de not_active IP Right Cessation
- 2002-04-12 EP EP05007851A patent/EP1550663A1/en not_active Withdrawn
- 2002-04-12 NZ NZ528560A patent/NZ528560A/en unknown
- 2002-04-12 CZ CZ20032760A patent/CZ20032760A3/cs unknown
- 2002-04-12 US US10/474,592 patent/US7217708B2/en not_active Expired - Fee Related
- 2002-04-12 EP EP02761972A patent/EP1389213B1/en not_active Expired - Lifetime
- 2002-04-12 WO PCT/SE2002/000725 patent/WO2002083688A1/en active IP Right Grant
- 2002-04-12 HU HU0303487A patent/HUP0303487A3/hu unknown
- 2002-04-12 ES ES02761972T patent/ES2261721T3/es not_active Expired - Lifetime
- 2002-04-12 EE EEP200300504A patent/EE200300504A/et unknown
- 2002-04-12 CN CNB028116283A patent/CN1269823C/zh not_active Expired - Fee Related
- 2002-04-12 SK SK1257-2003A patent/SK12572003A3/sk not_active Application Discontinuation
- 2002-04-12 BR BR0208829-0A patent/BR0208829A/pt not_active IP Right Cessation
- 2002-04-12 DE DE60210598T patent/DE60210598T2/de not_active Expired - Fee Related
- 2002-12-04 UA UA2003098709A patent/UA74629C2/uk unknown
-
2003
- 2003-10-03 ZA ZA200307759A patent/ZA200307759B/en unknown
- 2003-10-08 IS IS6980A patent/IS6980A/is unknown
- 2003-10-09 NO NO20034527A patent/NO20034527L/no not_active Application Discontinuation
-
2004
- 2004-06-08 HK HK04104077A patent/HK1061026A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1051193A1 (en) | (1,4')-Bipiperidine compounds. | |
| AP2002002695A0 (en) | Pyrrolo Ä2,3-dÜpyrimidine compounds | |
| IL160708A0 (en) | 1, 6-naphthyridine derivatives as antidiabetics | |
| HK1061852A1 (en) | 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity | |
| AU4787301A (en) | 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds | |
| ZA200005134B (en) | Solid, quick dissolving cetirizine formulations. | |
| IL158250A0 (en) | 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds | |
| HK1069171A1 (en) | Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents. | |
| MXPA03007693A (es) | Composicion para la piel. | |
| ZA200206779B (en) | Solid formulation. | |
| ZA200207341B (en) | Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7a]indole compounds. | |
| EG23378A (en) | Composition. | |
| IL158033A0 (en) | 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds | |
| IL158035A0 (en) | 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds | |
| IL162310A0 (en) | 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives | |
| MXPA03008077A (es) | Composicion humedecedora para la piel.. | |
| MXPA03005965A (es) | Composicion farmaceutica que contiene citalopram. | |
| SI1389213T1 (sl) | 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine | |
| PT1497256E (pt) | Compostos de 1,5-diaminopentan-3-ol substituídos | |
| IL159965A0 (en) | Novel 2,4-diaminothiazole derivatives | |
| PL352760A1 (en) | Oxathiepino[6,5-b | |
| MXPA03006632A (es) | Composicion solida. | |
| EG23305A (en) | Preparation of 1,2-dicloroethane. | |
| PL371851A1 (en) | 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |